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Abstract 
Background 
The usefulness of antibodies and antibody derived artificial constructs in 
various medical and biochemical applications has made them a prime target for 
protein engineering, modelling, and structure analysis. The huge number of known 
antibody sequences, that far outpaces the number of solved structures, raises the 
need for reliable automatic methods of antibody structure prediction.  
 Antibodies have a very characteristic molecular structure that is reflected in 
their modelling technique. Currently, the most accurate models are produced using 
a quite peculiar modelling strategy, developed among others by our group: the 
framework regions are modelled with a standard comparative modelling approach, 
whereas the hypervariable loops are predicted using the ad-hoc “canonical 
structure method”, historically based on expert analysis of the available antibody 
solved structures. More than thirty years passed since this modelling method was 
initially developed, nonetheless there is still a huge effort in the academic and 
pharmaceutical communities to improve its accuracy. The reason for this lies in 
several error sources in the current modelling process. First of all, given the large 
amount of available structures, it was impossible to manually update “canonical 
structure” classes and rules. Moreover, the lack of specific studies on the packing 
between the VL and the VH domains and on possible conformational changes 
occurring upon antigen binding was impairing the integration in the modelling 
techniques of such factors.  
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Aim 
The general aim of this study is to carry out an extensive characterization 
and annotation of immunoglobulin molecules i.e. to deepen our understanding of the 
molecular basis of their specificity using a combination of bioinformatics sequence- 
and structure-based analysis. I carried out improvements to the antibody modelling 
protocols by revising the canonical structure definitions and by minimizing the 
errors arising from VL and the VH domain packing at the same time by taking care 
of the conformational changes occurring upon antigen binding. 
Results 
During the past years, we successfully improved the description of the 
structural repertoire of immunoglobulins with lambda light chains, which has both 
practical (design, engineering and humanization) and theoretical applications 
(improvement of the antibody modelling)[1]. Our large-scale analysis of the 
association of heavy and light chain variable domains in antibodies showed that 
there are essentially two different modes of interaction that can be identified by the 
presence of key amino acids in specific positions of the antibody sequences [2]. 
Interestingly, we also found that the different packing modes are related to the 
volume and type of recognized antigen. These findings are clearly relevant for the 
design of antibodies and of antibody libraries. The investigation of the antibody 
conformational changes upon antigen binding allowed us to identify sections on 
variable and constant regions that show significant flexibility when comparing the 
antigen bound/unbound forms of immunoglobulins. The results of all the above-
mentioned analyses have been implemented in our in-house immunoglobulin 
structure prediction server (PIGS, automatic Prediction of ImmunoGlobulin 
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Structure), thus helping to minimize the sources of errors in the current modelling 
process. Consequent to our results, we were asked to write a chapter in 
Encyclopaedia of Biophysics on antibody modelling [3]. 
A further step in the direction of improving the understanding of antibody 
recognition mechanisms was to put together all the annotations of immunoglobulins 
in a publicly available database. To this aim, we constructed a database of 
immunoglobulin sequences and integrated tools (DIGIT) [4], which is becoming an 
extensively used resource by the community. DIGIT stores sequences of annotated 
immunoglobulin variable domains and offers to the user several tools for searching 
and analysing them.  
Our experience in antibody modelling allowed us to approach two 
biomedical problems in collaboration with Prof. Arcaini  (University of Pavia) and 
Prof. Fabio Ghiotto (University of Genova). More specifically, by applying the tools 
we developed and all our theoretical knowledge we successfully analysed the 
immunoglobulin repertoires of SMZL (splenic marginal zone lymphoma) and CLL 
(chronic lymphocytic leukaemia) patient data. Both the CLL and SMZL patients are 
known to have a biased usage of immunoglobulin (IG) heavy variable (IGHV) genes 
and stereotyped B-cell receptors (BCRs), used as a marker in disease prognosis. We 
extended these analyses by taking into account VL germlines, VL-VH pairing and 
structural information, thus giving a more detailed view of the immunoglobulin 
repertoire in terms of sequence, structure and function. Analysing the 
immunoglobulins of patients with CLL, we discovered statistically significant 
differences among immunoglobulins in patients with favourable and unfavourable 
prognosis. A paper describing this work has been submitted [5]. The poster 
describing the results of SMZL repertoire analysis was accepted at the 2012 
American Society of Haematology (ASH) meeting and published as an abstract [6].   
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Chapter 1 
1.1 General Introduction 
 
e live in extraordinary times. Advances in the life sciences day by 
day shed light on protein sequence, structure, and function 
relationship. We are more and more aware of confirmations and, even more 
interestingly, exceptions of the central tenet of molecular biology for which the 
function of a protein is completely determined by its three dimensional structure, 
that is in turn dictated by its sequence. 
The immune system is an extensive machinery that by orchestrating a complex 
network of regulatory mechanisms achieves an ample yet precise recognition of 
pathogens and foreign molecules, avoiding any potentially harmful response over 
self-molecules. Immunoglobulins (Igs, also known as antibodies, abbreviated Abs) 
are some of the molecules used by the immune system to adapt to huge number of 
different antigenic challenges: at any one time the average human body contains 
more than 106 different antibodies. Since their discovery in the first half of the 
W 
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twentieth century, antibodies have occupied a prominent role in several research 
areas as well as in a large number of bio-technological and clinical applications.  
The three dimensional structures of immunoglobulins and of proteins in general are 
determined mainly by two experimental techniques: X-ray crystallography and 
Nuclear Magnetic Resonance (NMR). The experimentally determined atomic 
coordinates are deposited in a public repository, the Protein Data Bank (PDB) 
(Berman et al., 2000). As of September 2012, there are approximately 2000 
immunoglobulin structures, whereas the number of antibody sequences currently 
available in public databases is two orders of magnitude larger. The reason for this 
increasingly huge gap between the number of structures and that of sequences (Fox 
et al., 2008) is that it can take months or even years to solve one structure, which 
can cost hundreds of thousands dollars, whereas sequencing techniques are much 
cheaper and faster. This increase in the number of antibody sequences with unsolved 
structure produced by various high-throughput techniques is bridged by an 
alternative that allows obtaining an accurate antibody structural model through 
computational modelling and prediction in a relatively automatic fashion.  
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1.2 Antibody sequence and structure 
1.2.1 Antibody structure 
Antibodies generally assume one of these two roles: i) plasma membrane 
bound antigen receptor on the surface of a B-cell (B-cell receptor) or ii) free 
molecules in cellular fluids functioning to intercept and eliminate antigenic 
determinants. In either role, antibody function is intimately related to its structure. In 
1959, a joint Nobel Prize was awarded to Edelman and Porter for their contributions 
towards the immunoglobulin properties by elucidating the basic primary structure of 
the immunoglobulin that can be written as H2 L2 (Figure 1). The molecule consists 
of four polypeptide chains, two heavy and two light, joined by disulphide bonds so 
that each heavy chain is linked to a light and the two heavy chains are linked 
together.  
 15 
 
Figure 1. Immunoglobulin structure. Heavy chains (grey, burgundy) and light chains (violet, brown) 
are shown in space-fill mode using Qutemol (http://qutemol.sourceforge.net). Fab, Fc and Fv regions 
are highlighted. 
 
Both the chains are usually divided in a Variable region (Fv, fragment variable, VL 
light and VH heavy) and a Constant region (CH and CL). The variable region is so 
named because its sequence varies from one immunoglobulin to another. In contrast, 
the constant region consists of an amino acid sequence that is conserved for 
immunoglobulins of the same isotype. There are four different light chain isotypes, 
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among which only two are found in mammals, namely the κ -kappa and λ- lambda 
type light chains. The heavy chains are of five types, designated as α, γ, δ, µ and ε 
chains and they define the class and the function of the antibody. The soluble form 
of an antibody and its membrane-bound counterpart are identical with the exception 
of a portion of the C-terminus of the heavy chain constant region. The heavy chains 
of membrane-bound antibody molecules have a hydrophobic C-terminus, which 
anchors them in the lipid bilayer of the B cell’s plasma membrane. The heavy chains 
of secreted antibody molecules, by contrast, have instead a hydrophilic C-terminus, 
which allows them to escape from the cell. 
1.2.2 Antibody hypervariable regions 
By analysing the Fv fragment, Wu and Kabat, (i.e. the dimmer of VH and VL 
domains, Figure 2) identified three sequence portions in the variable part of each 
chain, the so-called hypervariable regions, with an extremely variable amino acid 
composition in comparison with the other less variable parts (Wu and Kabat, 1970). 
It has been correctly predicted by the authors that these hypervariable regions 
assume a loop conformation arising from a relatively conserved framework and are 
responsible for the selective binding of the antigen. They therefore named them 
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“complementary determining regions” (CDRs) in contrast to the surrounding 
framework regions (FRs).  
 
 
Figure 2. Two views of the Ig variable domain. Light chain in red (light red: framework, full red: 
hypervariable loops), heavy chain in green (light green: framework, full green: hypervariable loops). 
Panel A reports a lateral view (antigen should be located on the topmost part of the Ig molecule), 
panel B depicts the antigen view of the same structure.  
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1.2.3 Antibody numbering 
In an attempt to standardize and eventually automate the comparative 
analysis of a large number of related immunoglobulin sequences and structures, the 
unambiguous identification of structurally equivalent residues is of crucial 
importance. Fortunately, the architecture of antibodies, in which variable regions are 
interspersed between regions that are extremely conserved both in sequence and in 
structure, allowed the development of several unified numbering schemes for their 
sequences. Such numberings unambiguously define portions or specific residues of 
immunoglobulins that have a similar position in the three-dimensional structure. 
Currently there are several such numbering schemes (Abhinandan and Martin, 2008; 
Al-Lazikani et al., 1997; Chothia and Lesk, 1987; Honegger and Pluckthun, 2001; 
Kabat and Wu, 1991; Lefranc, 1999).  
We describe here the Kabat-Chothia (KC) numbering scheme that is commonly 
adopted in antibody modelling. The Kabat numbering scheme was developed when 
none or little structural information was available. Chothia et al. analysed a small 
number of Ab structures and determined the relationship between the sequences of 
the Abs and the structures of their CDRs. Thus, the Chothia numbering scheme is 
almost identical to the Kabat scheme (they basically differ in the position of two 
 19 
insertions), but based on structural considerations. In the KC scheme each residue of 
the variable domains of both heavy and light chain is identified by a different 
sequential number with the only exception of insertions that may occur in the CDRs 
or in some positions in the FRs, which are identified by the number of the position 
in which the insertion occurs followed by consecutive letters. Figure 3 summarizes 
this scheme. It is worth mentioning that some conserved FR residues are present in 
almost all immunoglobulins. Such residues are extremely useful in identifying the 
various regions of the immunoglobulins and are reported in red in the figure. 
 
Figure 3. Kabat-Chothia numbering of VK, VL, and VH. The numbers above the sequences 
represent the KC numbering of specific residues, the remaining residues are numbered consecutively. 
Letters in blue correspond to insertions. Kabat definition of FRs and CDRs are highlighted in yellow 
and grey respectively, the Chothia and Lesk definition of hypervariable loops is indicated by arrows. 
Conserved residues are reported in red. 
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1.2.4 Antibody genetics 
To give a more complete picture of immunoglobulin sequence-structure-
function relationship, we will briefly describe some of the sophisticated mechanisms 
that the immune system developed to overcome the problem of recognizing a huge 
number of different antigens. The first source of variability is achieved in the Pre-B 
cell phase, when random assembling of gene segments generates the mature 
antibody genes. For the heavy chain in humans, selection and recombination takes 
place by the union of one from each of the 51 VH (“variable”), 27 D 
("diversity") and 6 JH ("joining") genes, followed by a series of 5 CH  ("constant") 
gene segments. The light chain loci (λ and κ in human) are formed by numerous V 
and J genes, but do not have D genes. The λ multigene family is formed by 30 Vλ 
gene segments, 4 Jλ gene segments, 4 Cλ gene segments, whereas the κ multigene 
family has 40 Vκ gene, 5 Jκ segments, and a single Cκ segment. The procedure of 
gene recombination is not precise and extra nucleotides are inserted during this 
process thus further increasing in a very effective way the number of possible 
antibody V region sequences. Another mechanism that augments the variety and the 
specificity of interactions with antigens and expands the potency of the 
immunoglobulin molecule is achieved through a process of random somatic 
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mutation. When a B cell recognizes an antigen, it is stimulated to proliferate. During 
proliferation, the rate of somatic mutation in the variable regions is extremely high, 
at least 105-106 folds greater than the normal rate of mutation across the genome. 
Considering the variability produced by all these events, together with the 
combinatorial effect on light and heavy chain selection, one can have an 
approximate picture of the mechanisms that create the huge structural variety of 
immunoglobulins and help to overcome the problem of recognizing an almost 
infinite number of antigens. 
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1.3 Methods for immunoglobulin structure 
prediction 
Antibody design, engineering and humanization partially or completely rely 
on the knowledge of the immunoglobulin structure. In the absence of an 
experimental structure, it is often possible to generate predictions of 3D structures 
by comparative modelling, (also known as homology modelling), as well as by de 
novo computational approaches. These modelling techniques often are reliable 
enough to be used in a very large number of applications, such as protein 
engineering (Morea et al., 1997a; Morea et al., 1997b) and docking (Pedotti et al., 
2011).  
 De novo modelling methods calculate 3D coordinates of the target protein, starting 
from its amino acid sequence alone, by means of knowledge-based methods and/or 
physics-based energy functions. Their major limitation is that, due to our limited 
comprehension of the physicochemical principles governing protein structures, the 
energy functions used to evaluate the different conformations often do not 
distinguish a correct prediction from an incorrect one, even when additional criteria 
are used to filter the results. Approaches combining knowledge-based and de novo 
methods have also been described (Martin et al., 1989). Comparative modelling is 
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based on identifying a protein of known structure homologous to the one to be 
modelled and using it as template to predict the structure of the target protein.  
Antibodies have very peculiar molecular structure and so is their modelling 
technique. The birth of antibody modelling techniques goes back to 1972, when 
Kabat and Wu carried out an analysis to determine the relationship between the 
amino acid sequences and the three-dimensional structures of the antigen-binding 
sites. They identified three hypervariable regions on both heavy and light chains, 
and correctly predicted such portions to assume a loop conformation arising from a 
relatively conserved framework and to be responsible for the selective binding of 
the antigen. The work of Chothia and Lesk extended this analysis by showing that 
five out of six regions (L1, L2, L3, H1 and H2) usually adopt just a limited set of 
discrete main-chain conformations. Moreover, they identified relatively few 
residues found within the hypervariable regions as well as in the conserved β-sheet 
framework that, through their packing, hydrogen bonding or ability to assume 
unusual φ, ψ or ω angles, are primarily responsible for the backbone conformations 
of the hypervariable loops. These classes of commonly occurring backbone 
conformations of the hypervariable regions, identified by the length of the loop and 
by specific key residues, were consequently named “canonical structures.” The sixth 
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hypervariable region (H3) is a specific case: it is the most variable loop in terms of 
sequence and structure and is found to contact the antigen in the majority of solved 
antibody-antigen structures. A sequence-structure relationship can only be found for 
the main chain conformation of the ten residues (four residues from the N-terminus 
and six residues from the C-terminus) of the loop proximal to the framework (the 
“torso” of the loop (Morea et al., 1998)).  
Thus, the peculiarity of the antibody molecules gives rise to an interesting modelling 
technique: the framework regions can be modelled using comparative modelling, 
whereas the hypervariable loops can be predicted based on the canonical structure 
method. The rules defining the canonical structures are being periodically revised 
and updated as more diverse antibody structures are solved (Al-Lazikani et al., 
1997; Chailyan et al., 2011a; Morea et al., 1998; North et al., 2011).  
Recently a blind study has been carried out to assess the state of the art in three-
dimensional structure modelling of the antibody variable region (Almagro et al., 
2011). The benchmark test set was composed by nine unpublished high-resolution 
X-ray Fab crystal structures. The Fv models generated by the four most successful 
immunoglobulin structure prediction methodologies were compared: two were 
generated by the homology modelling strategies independently developed by CCG 
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(Chemical Computer Group) and Accerlys Inc, and two were built using fully 
automated antibody modelling servers PIGS (Prediction of ImmunoGlobulin 
Structure) (Marcatili et al., 2008) and Rosetta Antibody (Sircar et al., 2009). The 
two web servers: PIGS (http://arianna.bio.uniroma1.it/pigs) and Rosetta Antibody 
Modelling Server (http://antibody.graylab.jhu.edu/) were developed in 2008.  
The PIGS is a tool developed by our group that predicts the conformation of the 
antigen-binding site based on the canonical structure method (Figure 4). The 
framework of Rosetta Antibody homology modelling server is the Rosetta structure 
prediction suite, comprising knowledge-based techniques for template selection, 
grafting for non-H3 loops, de novo loop modelling for creating H3, and docking to 
optimize the relative orientation of VH and VL domains. 
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Figure 4. Schematic view of the PIGS web server pipeline. The template structures for each of the 
user uploaded target sequences can be selected manually or according to a predefined strategy.  
Interestingly, when the models were compared to the x-ray structures average 
RMSD calculated over the backbone yielded the best values for PIGS, 1.1 Å. The 
RMSD values of ACC, CCG, and Rosetta models were slightly higher and 
remarkable similar: 1.3 Å, regardless of the method used to model the Fv region 
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and/or the modeller expertise. Average RMSD values for the FRs and hypervariable 
loops with canonical structures (L1, L2, L3, H1, and H2) were close to 1.0 Å for all 
methods. The major source of error in the process are the modelling of the H3 loop, 
the possible changes of conformation occurring upon antigen binding and the 
reconstruction of the correct packing between the VL and the VH domains.  
 
1.3.1 Caveats and open problems in antibody modelling  
As mentioned in the previous section, the errors in the modelling process 
arise mainly due to the H3 loop, the possible changes of conformation occurring 
upon antigen binding and the reconstruction of the correct packing between the VL 
and the VH domains.  
The first of the aforementioned problems is still being fronted in many different 
ways but the accuracy of H3 modelling is far below that of the rest of the model. 
This problem is crucial for example in modelling camelid VHH antibodies that lack 
the light chain and usually display extremely long H3 loops with a peculiar 
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conformational repertoire. Accurate prediction of H3 is of great importance also 
because of its direct involvement in antigen binding.  
Another open issue is the effect of antigen binding on the CDR loops conformation. 
Even though most of the loops display just a minor distortion upon antigen binding, 
the H3 loops (especially longer ones) can assume quite different conformations in 
the apo (unbound) and holo (bound) forms. It is therefore important to include this 
kind of information in the modelling process, and currently it cannot be achieved 
using the automated procedures described above. 
The last point regards the correct packing between VL and VH domains. Recently, 
we (Chailyan et al., 2011c) described the existence of at least two different packing 
modalities that have a strong impact on the shape of the antigen-binding site and on 
the antigen specificity. This becomes relevant if two different solved structures are 
used as templates for the framework of the two chains; in this case the regions 
modelled for each of the two templates need to be packed together in order to obtain 
the final model. This process may introduce deviations between the model and the 
real structure that can have a relevant impact on the structure of the ABS, located at 
the tip of the domains. In order to avoid this, the user can choose where possible, the 
same template (even though with a lower sequence similarity) for several loops 
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and/or frameworks, thus minimizing the number of superposition needed to build 
the final model. Such a choice is not trivial and depends on the existence of a 
suitable template with a good sequence identity. In a typical scenario, if the 
templates are selected using the highest similarity criteria they may come from 
different antibodies, therefore they have to be packed together and this may 
introduce errors. At the same time, if the same template is used for different regions, 
it may have a low sequence identity to the target, and therefore a lower expected 
similarity to the target.  
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1.4 Aim and contributions of the study 
The usefulness of antibodies and of antibody-derived artificial constructs in 
various medical and biochemical applications has made them a prime target for 
protein engineering, modelling and structure analysis. The purpose of the study 
described here is to carry out an extensive characterization and annotation of 
immunoglobulin molecules i.e. to deepen our understanding of the molecular basis 
of their specificity. Original results are described in three independent papers, which 
are included in the order in which they appear in the thesis. A short summary before 
each of the articles outlines the main rationale and results. The thesis also contains 
unpublished investigations on antibody conformational changes upon the antigen 
binding and applications of thesis concepts to biomedical problems, more 
specifically to the analysis of the immunoglobulin repertoires of SMZL and CLL 
patients.  
Chapters 2, 3, 4 and 5 outline the results of my studies.  The description of 
the structural repertoire of immunoglobulins with lambda light chains, which has 
both practical (design, engineering and humanization) and theoretical applications, 
is given in Chapter 2. Besides, this chapter contains also the investigation on the 
association of heavy and light chain variable domains in antibodies, showing that 
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there are essentially two different modes of interaction (relevant for the design of 
antibodies and of antibody libraries). Chapter 3 comprises the description of the 
database of immunoglobulin sequences and integrated tools (DIGIT), a much-
needed resource that stores sequences of annotated immunoglobulin variable 
domains enriched with tools for searching and analysing them. Finally, the chapter 4 
contains two applications of these tools and methods to biomedical problems. The 
first of such analysis focuses on the immunoglobulin repertoire of Splenic Marginal 
Zone Lymphoma (SMZL) patients and investigates the sequence-structure-antigen 
relationship in this disease. The second biomedical application concerns the analysis 
of the immunoglobulins of patients affected by Chronic Lymphocytic Leukaemia 
(CLL). Our findings on the structural differences in the immunoglobulins expressed 
by patients with favourable and unfavourable prognosis are described. Such results 
have been included in a paper, prepared in collaboration with Prof. Fabio Ghiotto 
that has already been submitted for publication. Finally, the investigation of 
immunoglobulin conformational change upon antigen binding is discussed in 
chapter 5. A paper describing this work, carried out in collaboration with Prof. 
Arthur Lesk, is in preparation. A general discussion is given in Chapter 6. 
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Chapter 2 
2.1 Structural repertoire of immunoglobulin λ light 
chains 
Improvements in immunoglobulin stability, affinity and suitability as therapeutics 
are often necessary for clinical and practical application, and they are in turn 
directly dependent to the knowledge of antibody three-dimensional structure. To this 
aim, bioinformatics methods come in hand when experimental data are not available. 
Standard homology modelling techniques are suitable to build models of the well-
conserved light and heavy chain framework only. The complementarity-determining 
regions, which are mostly composed by loops, would have been impossible to 
properly model in a standard scenario. Luckily, thanks to a large effort of the 
structural bioinformatics community, it was possible to develop the “canonical 
structures” method, a sort of dictionary of recurring CDR topologies to be used as a 
guide in the modelling of such regions. From a structural perspective, the 
classification of immunoglobulin hypervariable loops in a discrete set of 
conformation (the so called canonical structures, CS) (Al-Lazikani et al., 1997) 
became an indispensible ingredient for the majority of antibody structure prediction 
tools. A large amount of available structural data has permitted to define a discrete 
 33 
set of recurring topologies adopted by the main chain of hypervariable loops and, in 
the large majority of cases, sequence based rules to infer such CSs for two out of 
three heavy chain loops and for all the κ type1  light chain loops. Instead, a 
comparably detailed analysis has not been possible for λ chains, mainly because of 
the limited set of solved structures. Gaining an understanding of the 
sequence/structure relationship of the hypervariable loops of λ chains is of extreme 
relevance for both practical and theoretical reasons. To this aim, by means of a 
novel integrative approach of bioinformatics (structural superposition, sequence 
alignments, physiochemical analysis of structures), machine learning (clustering, 
random forests) and statistical (correlation tests, validation of predictions) 
techniques, we performed a large-scale analysis of the so far observed CSs in λ type 
light chains. We first defined the main sequence differences with respect to κ light 
chains by analysing more than 5000 Ig sequences. At this step, κ/ λ aligned 
sequences were compared and, using feature selection methods, the residues whose 
identity best discriminates between the two types of light chains were identified 
(Figure 5). The majority of such isotype specific positions had already been 
described as important to maintain the structure of the antigen binding-site (ABS), 
                                                
1 There are four isotypes of light chains encoded by different loci in vertebrates, only two of which, namely κ and λ 
types, are present in mammals. 
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suggesting that the structural diversity between the different isotypes reflects the 
evolutionary pressure related to their potential different role in the overall 
immunological response.  
 
Figure 5. The logo diagram in the upper panel shows isotype-specific positions, which are mapped 
on the structure of two antibodies with λ (PDB code 1A6U, in pink) and κ (PDB code 25C8, in blue) 
light chains after superposition of their heavy chains (in grey) in the lower panel. Residues at position 
29, 71, 90, and 97 influence the conformation of the antigen-binding site. The sequence logo was 
generated using the two-sample logo web server (Vacic et al., 2006).  
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On the next step, our in-house semi-automatic pipeline allowed us to define for each 
hypervariable loop of the light chain a set of canonical structures (eight for loop L1, 
two for L2 and five for L3) and to identify the amino acid positions that are most 
informative for predicting them from their sequence alone. Of course this analysis 
has a direct practical application to antibody modelling, but it also pointed at a very 
interesting observation: the conformational landscape of λ CSs is wider than that of 
κ chains, i.e. the hypervariable loops adopt a larger and more varied set of 
conformations. We believe the reason for this lies in the B cell ontogeny. It is 
thought that λ gene recombination follows, as a sort of  “rescue” mechanism, that of 
κ gene. The different role of the two isotypes is also supported by a bias in the κ 
chain codon usage towards more volatile codons (i.e. more subject to 
nonsynonymous mutations) both in the CDR and in the framework regions, 
favouring the insurgence of more drastic mutations. This suggests that the relatively 
lower probability of somatic diversity of λ chains is compensated by a larger 
genetically encoded structural variability that might reflect a different strategy in 
balancing genetic and somatic diversity adopted by the two light chain types to 
achieve ABS (antigen-binding site) differentiation. 
Interestingly, this diversity is related to subtype evolution: the majority of subtype-
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specific positions determined in this analysis play a role in shaping the conformation 
of the L1 and L3 loops and therefore of the ABS. Their conservation in the subtype 
germlines strongly suggests that structural diversity is a fundamental important 
feature driving the evolution of light chains. Moreover, the λ repertoire in human is 
larger than the corresponding murine one in terms of number of CSs. At last, 
surprisingly, unlike what is observed for κ and heavy chains, there is a very limited 
structural similarity between human and mouse CSs, which has obvious 
implications in selecting the appropriate strategies for humanization of 
therapeutically relevant antibodies. 
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2.2 The association of heavy and light chain variable 
domains in antibodies: implications for antigen 
specificity 
The success in clinical trials using antibodies with low toxicity and high 
efficiency has raised expectations for the development of next-generation protein 
therapeutics. Nevertheless, the process of obtaining therapeutic antibodies remains 
time consuming and empirical, and computational tools play a fundamental role in 
it. Reliable antibody models are indispensable in order to be able to design and 
engineer antibodies with improved affinities and physicochemical properties. The 
known pitfalls in this sense are to be found in these two tasks: (i) modelling the 
antigen-binding site (discussed in the previous chapter) and (ii) predicting the 
relative orientations of the variable heavy (VH) and light (VL) chains. At present, 
when building an immunoglobulin structural model, the models of the two chains, 
heavy and light, are built independently and next placed with each other. Previous 
studies (Davies and Metzger, 1983; Mariuzza et al., 1987; Narayanan et al., 2009; 
Novotny et al., 1983) have shown that the mode of interaction between the heavy 
and light chain variable domains can modify the relative positions of the 
hypervariable loops, which in turn, can alter the general shape of antigen-binding 
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site. In this study, we carried out a comprehensive analysis of the VH-VL interface 
of several currently available experimentally solved structures of immunoglobulins. 
This large-scale analysis showed that there are essentially two different modes of 
interaction of the domains that can be identified by the presence of key amino acids 
in specific positions of the antibody sequences (Chailyan et al., 2011b). Interestingly, 
we also found that the different packing modes are related to the size of recognized 
antigen.  
A complex pipeline developed by us allowed analysing the variability of VH-VL 
domain packing using cluster analysis based on a distance by LGA software. The 
number of antibody crystal structures with κ light chain in the PDB is much larger 
than that of antibodies with λ light chain, and thus we used a ‘balanced light chain 
set’, which included similar numbers of Vκ and Vλ antibody sequences, 
respectively. We found that VH-VL pairings can be divided into two major clusters 
where one cluster is only observed in mouse antibodies and the other is observed 
both in mouse and in human, indicating the importance of template selection in 
humanization procedure (Figure 6). We pointed out that these clusters could be 
assigned from the sequences by looking at some specific positions (L8, L28, L36, 
L41, L42, L43, L44, L66) in the sequences.  
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Figure 6. Results of the cluster analysis. Dendrogram based on the difference between the positions 
of residues at the interface in the light and heavy chain variable domains. The red line indicates the 
clustering with the highest silhouette value (0.47). In the bottom panel, red, green and blue indicate 
the A, B and C cluster, respectively. The type of light chain is shown in the bottom panel. 
 
An instructive example of the relevance of this study for antibody design can be 
found in the work by Worn and colleagues (Worn et al., 2000). These authors 
produced two single-chain Fv humanized intrabody versions of a murine anti-GCN4 
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immunoglobulin molecule (with a κ chain) using, as recipient, two human 
antibodies that differed in the type of light chain (κ in one case and λ in the other) 
and in only seven residues (including residues L36, L43 and L44). The κ-graft 
variant had an activity comparable with the wild-type antibody, whereas the λ -graft 
variant, although extraordinarily stable in vitro, had a five order of magnitude 
decreased antigen affinity, presumably, as the authors suggest, caused by differences 
in the mutual orientation of the two domains.      
Finally, we would like to mention that the ability of type B antibodies to bind 
smaller antigens, and the presence of the pocket described, might open up the 
possibility of using them as potential drug delivery vectors. Indeed, this has been 
proposed already in the case of the 1IND antibody (Love et al., 1993), a type B 
immunoglobulin with an exceptionally high affinity binding for an indium-chelate 
hapten.  
The ability to use sequence data to predict the mode of association of the variable 
domains of antibodies also has implications for methods to predict their structure. 
Indeed, the information obtained through the analysis described here is being used 
to implement a better prediction protocol in our PIGS immunoglobulin structure 
prediction server (Marcatili et al., 2008).  
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Chapter 3 
3.1 A database of immunoglobulins with integrated 
tools: DIGIT 
As the amount of biomedical information available in the literature continues 
to increase, databases that aggregate this information continue to grow in 
significance and scope. Given the importance of studying the antibody 
sequence/structure function relationship, the need to have organized data is even 
more evident because of an overgrowing urgency to gain an overall view of the 
immune repertoire and of its dynamics. This is of primary importance in many 
practical applications (e.g. vaccine development) and theoretical breakthroughs (e.g. 
to find out similarities and differences between B-cell receptors in pathogenic 
diseases, autoimmune states and lymphoproliferative disorders). This so-called “-
omic” perspective of course necessitates all the publicly available data on 
immunoglobulins to be annotated and organized in a database and ready to be 
integrated and analysed.  
Unfortunately, all the annotations that include information on the type of antigen 
that an antibody binds, its germline sequences and the pairing between light and 
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heavy chains were scattered in literature and thus couldn’t altogether be retrieved 
from any supported database. To this aim, taking advantage of our experience and 
suggestions from our experimental collaborators we constructed a database of 
immunoglobulin sequences and integrated tools (DIGIT) (Chailyan et al., 2011d), a 
resource that stores sequences of annotated immunoglobulin variable domains 
enriched with tools for searching and analysing them. In less than one year it 
became an extensively used resource by the community (more than 1,300 queries 
and 800 unique users). 
At the current state the database houses 145,759 heavy chain sequences and 71,404 
light chain sequences (47168 kappa type and 24236 lambda type) retrieved using 
isotype-specific HMM profiles developed by us, with assigned canonical structures 
for the hypervariable loops.  
The user can query the database using the antigen type, source organism, accession 
number, chain type (heavy, lambda, kappa, lambda+kappa) or free text (disease, 
process etc.) with the option of selecting only complete immunoglobulins (VL+VH). 
Other annotations are computed on the fly (and therefore can also be obtained for 
user submitted sequences), for example: 
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1) Numbering of the sequence according to the Kabat numbering scheme 
2) Identifications of the Complementary Determining Regions (CDRs) in the 
sequence and of the Framework Regions (FRs) 
3) Assignment of the canonical structures for the CDRs  
4) Identification of mutations with respect to the germline  
5) Automatic link to our 3D modelling tool for immunoglobulin variable 
domains. 
6) Sequence searching that, given the input immunoglobulin sequence of 
interest (amino acid or nucleotide sequence of heavy chain variable domain 
sequence; light chain variable domain sequence or both), retrieves the closest 
sequences (sorted according to e-value or % id). 
Human annotated complete antibody sequences of the database are approximately 
2,500 (i.e. with both light and heavy chains). Among those, more than 1,000 have 
some information on the antigen, more than 250 are annotated as autoimmune or 
autoantibody, more than 400 have been sequenced in lymphomas or leukaemias, 
making possible aforementioned analyses. We are convinced that DIGIT might be 
extremely useful to researchers interested in immunology as well as to scientists 
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performing experiments such as antibody humanization, stabilization and 
functionalization. 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 45 
Chapter 4 
4.1 Hierarchical Clustering of B-Cell Receptor 
Structures in Splenic Marginal Zone Lymphoma 
Our long lasting experience in antibody modelling allowed us to approach 
two biomedical problems raised in collaborations with Prof. Arcaini  (University of 
Pavia) and Prof. Fabio Ghiotto (University of Genova). More specifically, by 
applying the developed tools and all our theoretical knowledge we carried out a 
comprehensive annotation of the repertoires and the characteristics of 
immunoglobulins from patients with splenic marginal zone lymphoma (SMZL) and 
chronic lymphocytic leukaemia (CLL) providing novel insights into the molecular 
mechanisms and the etiology of two the diseases. The following chapter describes in 
detail the multilayer characterization of the sequence and structure properties of 
SMZL patient samples and points to both “normal” antigenic and superantigenic 
simulation. 
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4.1.1 Background 
Splenic marginal zone lymphoma (SMZL) is recognized by the WHO 
classification as an individual entity, it is frequently associated with HCV infection 
and autoimmune disorders. SMZL is a disease with currently unknown molecular 
pathogenesis. Several studies pointed that it may be associated with a chronic 
antigenic stimulation, in fact previous studies by other groups and us demonstrated 
that SMZL presents a biased usage of immunoglobulin (IG) heavy variable (IGHV) 
genes and stereotyped B-cell receptors (BCRs), confirming the likelihood of 
involvement of antigens and/or superantigens in lymphomagenesis. This 
characterization, however, is mainly based on the heavy chain alone, even if strong 
evidences are emerging on the role of light chain (Bikos et al., 2012). The aim of 
this study was to extend the current analysis of SMZL samples by taking into 
account Ig light variable genes (IGLV), VL-VH pairing and structural information, 
thus giving a more detailed view of the immunoglobulin repertoire in terms of 
sequence, structure and function, and to investigate the sequence-structure-antigen 
relationship. 
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4.1.2 Results 
In this study for the first time the VL-VH paired sequences of 
immunoglobulins from SMZL patients diagnosed according to Matutes criteria 
(Matutes et al., 2008) have been extensively analysed. Sources for analysis were 
bone marrow in 38 cases and peripheral blood in 14 cases. Ig rearrangements have 
been characterized by amplification and direct sequencing. Sequences were 
analysed using the IMGT/DBs and the IMGT/V-QUEST tool. The PIGS web server 
was used to build 3D models of all antibodies (Abs). The Ab structures were 
compared using LGA and clustered together according to a score accounting for 
structure and sequence similarity. Using the DIGIT DB and tools, Igs of all the 
clusters were analysed and compared to other Igs.  
Based on the IGHV nucleotide sequence identity to the germline, 7 sequences (13%) 
were considered ‘truly unmutated' (100% sequence identity), 20 (39%) were 
‘minimally or borderline mutated' (97-99.9%) whereas 25 (48%) were ‘significantly 
mutated' (<97%). IGHV families were used as follows: IGHV3 (58%), IGHV1 
(27%) and IGHV4 (15%). The majority of patients carried kappa light chain (69%). 
The most frequently used IGKV families were IGKV3 (58%) and IGKV1 (28%), 
the most frequent IGLV family was IGLV1 (56%). Considering the VL-VH paired 
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sequences, the two pairings IGHV3-23/IGKV3-20 (n=6) and IGHV1-02/IGLV1-47 
(n=3) were significantly over-represented when compared to CLL and DIGIT DB 
sequences (Figure 7), indicating that the pairing between VL-VH chains was non-
random. The IGHV1-02/IGLV1-47 paired sequences showed a high number of 
somatic mutations (>3%), whereas samples using the IGHV1-02 gene (n=10) but a 
VL gene other than from IGLV1-47 displayed a low number of mutations, 
suggesting a significant role for the light chain. 
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Figure 7. Biased usage of VL/VH pairing in SMZL. The closest light chain germline gene is on the 
X-axes, the closest heavy chain germline gene is on the Y-axes. Colour code:  the redder the dot on 
the cross is the bigger the number of immunoglobulins with that specific VL/VH pairing. 
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In order to reveal the possible functional role of light chain, we analysed the 
structural similarity of Ag binding sites (ABSs), performing hierarchical clustering 
on the similarity obtained by an all-against-all structural superposition of each ABS. 
Twenty structural clusters were identified (8 with ≥ 3 samples) (Figure 8). Igs in the 
same major groups showed a similar mutation rate, pointing out a likely common 
Ag selection at least in a fraction of patients. In most cases, Igs in the same clusters 
display ABSs with similar physicochemical characteristics: positively charged 
binding sites (2 clusters), hydrophobic patches (3 clusters) or small pockets in the 
middle of the ABS (3 clusters) that might be clue for different Ags specific for each 
cluster. HCV infection was found in 1 major and 2 minor clusters (Figure 8), mainly 
associated with unmutated clones, indicating a likely common antigenic stimulation. 
In the other major clusters, the role for an Ag-driven selection different from HCV 
in SMZL lymphomagenesis can be postulated. In particular, 3 clusters, containing 
both mutated and unmutated samples, displayed a statistically significant similarity 
to CLL clones (p<0.05), and 1 cluster was structurally similar to autoimmune clones 
(Kawasaki disease) (p=0.05). Of note, other clusters showed a degree of similarity 
with samples connected to diseases that involve an Ag-independent or 
superantigenic stimulation (EBV, Rabies virus, Rotavirus). 
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Figure 8. Hierarchical Clustering of B-Cell Receptor Structures in Splenic Marginal Zone 
Lymphoma. The bottom panel shows the status of the mutation and HCV prognosis. The number of 
clusters is defined based on silhouette value. 
4.1.3 Discussion 
The multi-layered characterization of the sequence and structure properties 
of paired VL-VH in SMZL identified a non-random pairing between heavy and light 
chains. Structural cluster analysis identified Abs with similar physicochemical 
properties, similar mutation rate and similar HCV status in a fraction of our dataset. 
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Comparing Abs of our cases to a large dataset of human annotated Abs derived from 
the DIGIT DB, a subset resulted similar to CLL or autoimmune clones, whereas 
other Abs appeared more similar to polyreactive Abs and to Abs possibly targeted 
by superantigens (Figure 7). These findings could explain the large diversity 
observed in the Igs expressed in SMZL and provide new insights in SMZL 
pathogenesis. Future large-scale analysis is anticipated. 
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4.2 Structure variability of immunoglobulins 
expressed by B cells in chronic lymphocytic 
leukaemia 
4.2.1 Background 
 Chronic lymphocytic leukaemia (CLL) is a cancer of the blood cells that 
affects B-lymphocytes. CLL pathogenesis is still unclear, but several factors 
contribute to the evolution and the expansion of the mature B-lymphocytes 
(Chiorazzi et al., 2005). The disease is heterogeneous and some patients progress 
rapidly having a short survival, whereas others have a more stable clinical course 
that may not need treatment for years. Interestingly, in ~ 50% of clones, the IGHV 
and IGL/KV regions of Igs expressed on the surface of leukemic cells undergo 
somatic hypermutation (SHM) (Fais et al., 1998; Hadzidimitriou et al., 2009), and 
patients expressing such clones usually have a more indolent clinical courses with 
respect to those with unmutated ones (Hamblin et al., 1999). Last but not least, CLL 
clones of different patients may rearrange Igs with remarkable similarities (Ghiotto 
et al., 2004; Tobin et al., 2003). These so called “stereotyped Igs” are mainly 
characterized by their HCDR3 amino acid composition and length and recently a 
large-scale confirmation study of thousands of CLL H chain IGVs showed that the 
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30% of CLL cases fall within one of more than 300 described subgroups of 
stereotyped Igs (Agathangelidis et al., 2012; Murray et al., 2008).  
All the previously exposed experimental evidences, i.e. the presence of somatic 
mutations, the biased use of certain IGHV genes and the presence of "stereotyped" 
immunoglobulin complementarity-determining region-3 (HCDR3) sequences, 
indicate that antigenic exposure of B cells might play an important role in the 
etiology and progression of CLL. If this is the case, even though the HCDR3 plays a 
crucial role in the antigen-Ig interaction, a comprehensive analysis of the whole 
ABS structure is expected to give a more complete view of the molecular 
characteristics of receptors and possibly on the antigen pressure involved in CLL. 
 Therefore, we analysed here for the first time the structures of Igs from CLL 
patients, in order to assess whether the structural information on the ABS can 
provide novel insights into the antigen-driving role in CLL pathogenesis. 
4.2.2 Materials and Methods 
 We analysed the paired (VL+VH) sequences of 366 patients affected by CLL. 
For the analysis of Ig structural features, the PIGS server was used to derive the 
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sequence alignments of the Ig frameworks (using the Kabat-Chothia numbering 
scheme as reported in (Al-Lazikani et al., 1997)) and to build three-dimensional 
models of 342 among 366 Igs in our dataset. An all-against-all structural alignment 
of the antigen-binding sites was performed using the LGA package (Zemla, 2003) in 
order to group together structurally similar receptors. To this aim, we used several 
distance measures (RMSD, Global Distance Test (GDT) and Template Modelling 
(TM) score) and clustering methods (agglomerative hierarchical clustering and 
divisive hierarchical clustering with a number of clusters ranging from 10 to 50) and 
selected, by means of the silhouette analysis (PJ, 1987), the one that held to the best 
cluster topology, i.e. that was able to produce tight and well-separated clusters. The 
best average silhouette value was obtained with TM-score, divisive clustering 
method and 21 clusters. The 15 out of 21 clusters containing more than 5 samples 
were used for all subsequent analyses. 
We then performed a comparative analysis of the information of 3D ABS structural 
model versus that of the linear VH sequence. In order to do this, we built a 
clustering of the CLL dataset samples (342 patient Igs) based on sequence similarity 
alone. For both the structure-based and the sequence-based clustering results we 
generated statistical models of their members in the form of HMMs. All the HMMs 
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were then used to score a large dataset of 2441 human Igs included in the DIGIT 
database (Chailyan et al., 2012). 
4.2.3 Results  
Structural clustering of the 342 CLL Igs according to their ABS structural similarity 
displays a strong correlation with the Ig mutation status, which is one of the most 
common prognostic factors in CLL. We used a 2-class partition with a 2% cut-off 
for defining M (mutated) and U (unmutated) groups to identify the mutation level of 
Igs. For each cluster we computed the probability that an equal or higher number of 
Igs belonging to the same class could be found by chance in a randomly extracted 
subset of the same size (hypergeometric distribution). The Bonferroni-Holm (BH) 
method was used to correct for multiple testing.  We found that M- and U-CLL Igs 
segregated with a significant over-representation of either M or U Igs in 5 out of 15 
clusters thus showing that the structural features of 180 out of the 342 clustered Igs 
correlate with their mutation status, supporting the hypothesis of an active role of 
antigen selection. 
Apart from the structural similarity, most members of the clusters also shared 
properties such as type of light chain, stereotypes and in some cases homogeneity 
 57 
also in terms of the IGHV-IGK/LV usage and H/L chains pairing. Interestingly 
enough, such structural clusters were CLL specific. If we build statistical models of 
each cluster and use them to assign a score to samples not present in our dataset we 
obtain scores significantly higher for CLL samples with respect to non-CLL ones. 
Additionally, only samples annotated as autoimmune or autoreactive have scores 
comparable to the CLL ones, in accordance to previous literature (Herve et al., 
2005). Such results depend on the structural similarity adopted to cluster the ABSs 
and not to sequence similarity alone: if the same procedures described above are 
repeated on a clustering obtained by mere sequence similarity no discriminative 
power between CLL and non-CLL samples is observed. This result strongly 
suggests that CLL specific features of the Igs are intrinsic to the atomic structure of 
the binding site and hints to the involvement of antigenic structures in CLL 
pathogenesis. 
4.2.4 Discussion 
 No definite answer has to be found to the question whether the B 
lymphocyte clones found in CLL patients display a selective specificity for a 
restricted number of antigens. Support to this hypothesis is provided by the 
existence of stereotyped IgV rearrangements, even though they are present in a 
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minority of CLL cases. This is likely due to the definition of stereotyped BCRs, 
mostly based on the HCDR3 amino acid sequence alone.  
In this work we modelled and analysed the structure of CLL Ig ABSs, and we found 
a limited repertoire of conformations that is CLL specific. When compared to non-
CLL samples, this repertoire presented a degree of similarity to autoreactive 
samples. Clusters of similar receptor often shared a similar mutation rate, suggesting 
the presence of some functional constraint that is likely to be related to the structure 
of the binding site.  
This is the first time that immunoglobulins from CLL patients are analysed from a 
structural point of view, and we believe that our results point to the relevance of 
using this approach on a larger scale, which can now be easily handled by current 
methodologies for modelling and structural analysis.  
The correlation between antigen-binding site structure and clinical outcome, if 
confirmed, may provide novel tools for a more robust prognostic stratification of 
CLL also thanks to the fact that sequencing of the IgVL can easily become a 
standard laboratory test, as it is already the case for IgVH sequencing and the 
modelling and clustering protocols are very well defined and available. 
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At present it is essentially impossible to identify the antigen given the structure of 
the cognate antibody-binding site, but this might change in the future and hopefully 
we might also be able to gain insight in the nature of the antigens associated with 
CLL pathogenesis, which would obviously have important applications for therapy.  
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Chapter 5 
5.1 Antibody conformational change upon antigen 
binding 
5.1.1 Background 
The immune system is a major area for the studies on molecular recognition, 
given its ability to produce a finite number of antibodies that must bind a virtually 
infinite range of foreign molecules. Several experimental and structural studies 
evidenced that antibodies show flexibility upon antigen binding, which might play 
an important role in antigen recognition and in immunoglobulin function in general. 
Conformational change in Abs has been widely recognized, albeit its role in 
immunoglobulin function and adaptive immunity in general has not been 
satisfactorily elucidated yet. The limitation created by the small amount of 
experimentally solved antibody structures has led to several controversial reports. 
Some of the studies highlight small overall changes, movements of side-chains and 
changes in the VH-VL relative orientation, whereas others point at large 
conformational changes and rearrangement of the CDRs. Thus the topic is well 
discussed in the literature and at the same time is full of open issues.  
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Basing on their sequence variability, immunoglobulin polypeptide chains can be 
divided in two functionally distinct regions: the “variable region”, that is responsible 
for the binding of antigens, and the conserved “constant region”, that is known to 
participate in signalling events, such as the activation of the complement cascade. 
The central dogma of immunology claims that the specificity of the antibody is 
solely a result of the interaction between the immunoglobulin variable region with 
the antigen, but recent studies highlighted the importance of the constant region in 
antibody affinity and specificity. For example, Pritsch et al. (Pritsch et al., 1996) 
found that two human mAbs that share identical variable domains but use different 
heavy chain isotypes bind with significantly different affinities the same antigen 
(tubulin). Since the sequence differences observed by the investigators were found 
at the CH1 domain level, the authors suggested an active role of this domain in the 
affinity. A similar work by Casadevall (Torres and Casadevall, 2008) showed that 
four mAb isotypes that share identical variable domains undergo different structural 
changes upon the binding to common Ag, hinting at structural cross-talk between 
constant and variable domains. 
Thus, all these evidences raise the fundamental question of how the binding of an 
antigen to an antibody Fab site can trigger reactions in the distant FC domains and 
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what are the crucial residues that are responsible for the transmission of structural 
changes from the constant region to the variable region and vice versa.  
In this study, we describe a general large-scale analysis of the antibody binding 
characteristics. By comparing all antibodies with experimentally determined 
structures both in free and antigen bound form we will provide information about 
statistically significant structural modifications at a residue level in both variable 
and constant domains (side-chains movements, site-specific changes, change in the 
relative orientation of variable domains, changes in the relative orientation of 
variable and constant domains). 
 5.1.2 Material and Methods 
Dataset “AB” 
We scanned the sequences of proteins with solved structure present in the 
PDB database (Dutta et al., 2009) with in-house HMM profiles (for kappa, lambda 
and heavy chains) to identify immunoglobulin structures (obtaining 1294 molecules). 
Next, all the structures with unresolved residues in the VH-VL domains have been 
removed and the resulting dataset has been renumbered according to Kabat-Chothia 
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(i.e. structurally-derived) numbering scheme. We also removed Bence Jones 
proteins, heavy chain dimers and immunoglobulins with missing residues 
indispensable to correctly identify the ABS (Cys 23_L, Cys 22_H, Phe 98_L, Trp 
103_H). We used an in house routine to define whether the immunoglobulin is in 
apo (unbound) or holo (bound by ligand) state. To this aim we checked if any atom 
not belonging to the immunoglobulin light or heavy chain is in a 10Å radius from 
the ABS barycenter. When such atoms were present, the antibody was labelled as 
“bound” and all the chains to which these atoms belong were considered as 
“antigens”, with the only exception of small molecules (for which the chain label in 
the PDB file usually coincides with either the light or heavy chain label) where only 
the atoms belonging to the molecule itself were added. This procedure allowed us to 
carry out the study without regard of the type of antigen, thus selecting also haptens 
that have been recently found to induce conformational change in antibodies. For all 
the cases in which the antigen identified with the aforementioned routine was an 
antibody itself we performed a manual checking of the corresponding article and 
removed the Igs that were not described as anti-idiotype, considering the contact as 
an artefact of the crystal structure. We excluded from the analysis all the Igs (28 
structures) for which the RMSD calculated on the Cαs of multiple copies after 
superimposing the core of their variable regions (light chain=20_L: 98_L; heavy 
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chain=20_H: 101_H) was larger than 0.6 Å (this value being the average RMSD of 
multiple copies in our complete dataset plus one standard deviation). Next, the 
resulting dataset (864 Ig structures) has been culled by resolution (2Å, using the 
PISCES web server (Wang and Dunbrack, 2003)) and by B-factor, excluding the 
structures with a B-factor of any backbone atom (C, Cα , O, N) more than 80. The 
final dataset contained 265 immunoglobulin structures. In order to collect all the 
structures of the same antibody in apo and holo states, we grouped the 
immunoglobulins according to the sequence similarity. Two structures were 
considered as being of the same antibody if both of their chains shared 100% 
sequence identity. This allowed us to obtain 37 groups containing at least 2 Ig 
molecules, among which 14 contained at least 1 apo and 1 holo solved structure of 
the same antibody (dataset AB_VAH, AB variable apo-holo), 20 groups contained 
the Igs solved just in holo state (dataset AB_VHH, AB variable holo-holo) and 3 
groups were composed of immunoglobulins in apo state. Finally, we performed all 
the possible apo-holo and holo-holo comparisons inside each group (for example, if 
the group contains 1 Ig in apo state and 3 Igs in holo state, we perform 3 
comparisons of Igs in apo-holo state and 3 comparison of the Igs in holo-holo state), 
obtaining 25 apo/holo pairs in the AB_VAH dataset and 82 holo/holo pairs in the 
AB_VHH dataset.  
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Dataset “AB_constant” 
Starting from the AB_VAH and AB_VHH datasets we derived two datasets 
composed of immunoglobulins with identical variable and constant domains (first 
constant domain of the heavy chain, CH1 and constant domain of the light chain, 
CL) sequences. First, we removed from the AB_VAH and AB_VHH datasets the 
Igs that have missing residues in the constant domains. Next, similarly to what we 
did for the variable domains, we grouped the immunoglobulins by considering two 
structures to be of the same antibody if both their chains shared 100% sequence 
identity. The final AB_CAH (dataset AB constant apo-holo) dataset contained 17 
apo-holo pairs derived from 10 groups of different experimental structures of the 
same antibody, whereas the AB_CHH (dataset AB constant holo-holo) dataset 
contained 24 pairs from 8 groups. All the datasets with the corresponding number of 
immunoglobulins and pairs are presented in Table 1. 
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Table 1. The AB dataset content. 
 VAH                  VHH 
Variable region 
CAH               CHH 
Constant region 
Number of groups 	   14 Igs 20 Igs 10 Igs 8 Igs	  
Number of pairs	   25 pairs	   82 pairs	   17 pairs 24 pairs	  
 
Structural superposition 
Variable region “AB” dataset, Constant region “AB_constant” dataset 
 The analysis described below was performed separately for the variable and 
constant domains. All the immunoglobulins of the four datasets (AB_VAH, 
AB_VHH, AB_CAH, AB_CHH) were renumbered according to the Kabat-Chothia 
numbering scheme in order to identify the corresponding positions. For each pair of 
the AB_VAH and AB_VHH variable domain datasets we performed an all-against-
all structural superposition of the whole variable domain comprising residues 1-110 
for the VL region and residues 1-113 for the VH region. The structural 
superposition has been carried out by LGA package with the following parameters: 
sequence dependent analysis and cut-off threshold of 10 Å. For each structural 
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alignment we calculated the Cα root-mean-square deviation (RMSD) per each 
position of the variable domain sequence.  
Similarly to what has been done for variable domain, we performed structural 
superposition of the whole constant domain (CL=> 110-210; CH1=> 113-213) 
independently from variable domains with subsequent Cα RMSD calculation.  
 Table 2. The loop regions with corresponding residues according  
to Kabat-Chothia numbering scheme. 
 
 Residues	  
L1 loop 24-34	  
L2 loop 48-54	  
L3 loop 89-98	  
H1 loop 24-34	  
H2 loop 51-57	  
H3 loop 94-103	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5.1.3 Results 
An increased number of solved structures allowed us to investigate the 
hypothesis of conformational changes upon antigen binding by means of a 
comparative analysis of free and bound forms of the same antibody. In this analysis 
we used pairs of structures of the same antibody determined with or without its 
corresponding antigens. The dataset used for the analysis of variable domains 
consists of 100 PDB structures of 34 different antibodies. We performed not only 
bound-unbound comparisons, but also bound-bound comparisons of the same 
antibody to provide a control that allows determining whether the change is 
unequivocally determined by antigen binding. Overall this dataset consists of 25 
bound-unbound and 82 bound-bound pairs of structures of the same antibody. We 
identified changes occurring at a residue level by performing a structural 
superposition of bound-unbound and bound-bound pairs and calculated the RMSD 
for Cα atoms of structurally equivalent residues. The results of this analysis 
averaged for all the immunoglobulins of the dataset are shown in Figures 9 (heavy 
chain) and 10 (light chain). Cα fluctuation of each residue of bound-unbound pairs 
is shown in blue, whereas of bound-bound pairs are depicted in red. In almost all 
positions, the RMSD calculated between free and bound structures is greater than 
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the RMSD between the two bound structures. Besides the hypervariable loops that 
showed flexibility as a result of direct interaction with antigen, we identified two 
loop regions far from ABS on the heavy (residues 40-44) and light chain (41-45) 
variable domains, that interact with each other and are part of heavy-light interface. 
X1_H X5_H X9_H X13_H X17_H X21_H X25_H X29_H X32_H X36_H X40_H X44_H X48_H X52_H X53_H X57_H X61_H X65_H X69_H X73_H X77_H X81_H X83_H X87_H X91_H X95_H X99_H X100D_H X102_H X107_H X112_H
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Figure 9. Cα fluctuation in apo/holo (blue) vs holo/holo (red) immunoglobulin pairs. Heavy chain 
variable domain. X-axis residue number, Y-axis RMSD of Cα atoms between apo/holo and holo/holo 
Ig pairs. 
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Figure 10. Cα fluctuation in apo/holo (blue) vs holo/holo (red) immunoglobulin pairs. Light chain 
variable domain. X-axis residue number, Y-axis RMSD of Cα atoms between apo/holo and holo/holo 
Ig pairs. 
 
Taking into the account recent evidences of the constant region importance in Ag 
binding, we analysed also the first constant regions of immunoglobulin heavy and 
light chains. In this case the pairs of structures that share 100% sequence identity in 
both variable and constant domains of H and L chains (first constant heavy and 
constant of light chain) have been used. For this analysis 50 PDB structures 
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representing 18 different antibodies make up the dataset. As before, we compared 
the differences noticed in the bound-unbound superpositions to those observed in 
bound-bound superpositions of the same antibody to provide a control that allows 
determining whether the change is related to antigen binding. Thus, the overall 
number of bound-unbound pairs in this analysis was 17 whereas the number of 
bound-bound pairs was 24. As for the variable domain, we identified changes 
occurring at the residue level by performing a structural superposition of bound-
unbound and bound-bound pairs and calculated the RMSD for Cα atoms of 
structurally equivalent residues. The results of this analysis averaged for all the 
immunoglobulins of the dataset are shown in Figures 11 (heavy chain) and 12 (light 
chain). Cα fluctuation of each residue of bound-unbound pairs is shown in blue and 
bound-bound pairs are depicted in red. The RMSD calculated between free and 
bound structures was greater than the RMSD between the two bound structures, 
indicating that these changes are related to Ag binding. This analysis allowed 
identifying a loop region in CH1 domain of the heavy chain (residues 126-138) that 
undergoes substantial changes upon Ag binding (Figure 11). Since this loop, 
implicated in the interaction between H and L chains, has been described as being 
intrinsically disordered in specific conditions and is involved in complement 
binding, we think it may have a role in Ab function. We are currently performing 
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further work on identifying the structural bases of the signal transduction from 
constant to variable region and the role of Ag type in it. Similar analysis on side 
chains, analysis of the heavy-light chain relative orientation and CDR comparisons 
are in progress. 
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Figure 11. Cα fluctuation in apo/holo (blue) vs holo/holo  (red) immunoglobulin pairs. Heavy chain 
constant domain. X-axis residue number, Y-axis RMSD of Cα atoms between apo/holo and 
holo/holo Ig pairs. 
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Figure 12. Cα fluctuation in apo/holo (blue) vs holo/holo  (red) immunoglobulin pairs. Light chain 
constant domain. X-axis residue number, Y-axis RMSD of Cα atoms between apo/holo and 
holo/holo Ig pairs. 
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Chapter 6 
6.1 Conclusions and outlook 
Nowhere is the importance of complex dynamics and architectures clearer than in 
biological systems. Novel experimental techniques and data give us the opportunity 
to explore this complex world, with the aid of different frameworks, models and 
tools since in biology, in most of the cases, complex questions require complex 
answers.  Even when considering a single protein family, the immunoglobulins, 
such complexity cannot (or at least not yet) be reduced to a single framework. In 
order to gain useful information, one has to integrate interactions with expression 
data, structures, mutation experiments, medical information and sequences. 
Integrating all these data and methods in a biologically meaningful framework is an 
extremely hard though exciting task. In this work I present a number of these 
methods, developed by our group and published in the papers reported in the final 
section of this thesis, that share the common line of switching from the single-case 
analyses of Igs that has been carried out since now to a systematic analysis. 
The first part of the thesis describes the theoretical tools developed to analyse the 
antibodies in a comprehensive way. These tools were used to help the antibody 
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modelling and to develop a database of immunoglobulins. Whereas, the second part 
demonstrates how these tools and theoretical knowledge let us give a 
comprehensive description of the repertoires and the characteristics of 
immunoglobulins in two diseases (CLL and SMZL) that confirmed the results of 
previous studies and revealed new features that can be useful as diagnostic markers 
in the prognosis of these diseases and hopefully shed a light on its causative agents. 
The role of immunoglobulin molecules is quite well known, nevertheless some 
basic questions are still open and it is never quite straightforward to find the 
answers since its understanding is often a hard if not impossible task. We hope that, 
in this work, we were able to give an at least partial picture of this scenario and to 
answer some biologically relevant questions. 
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